Methylphenidate Sales Data
| Rank 38 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows methylphenidate U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 38 ( 1) |
$327,346 | 2.26% | 793 | 10.45% |
| Q3 2013 | 39 ( 4) |
$320,126 | -9.31% | 718 | -7.24% |
| Q2 2013 | 35 (2) |
$352,988 | -7.92% | 774 | -6.30% |
| Q1 2013 | 33 (4) |
$383,354 | -4.09% | 826 | -1.90% |
| Q4 2012 | 29 (9) |
$399,702 | 15.21% | 842 | 17.76% |
| Q3 2012 | 38 (3) |
$346,945 | 0.01% | 715 | -2.19% |
| Q2 2012 | 41 (4) |
$346,906 | 2.88% | 731 | -5.19% |
| Q1 2012 | 45 (5) |
$337,211 | 11.27% | 771 | 12.23% |
| Q4 2011 | 50 (2) |
$303,055 | 16.12% | 687 | 15.85% |
| Q3 2011 | 52 (31) |
$260,992 | 41.59% | 593 | 40.86% |
| Q2 2011 | 83 ( ) |
$184,330 | n/a | 421 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
